AtriCure Announces Multi-Year Project to Expand Global HQ

CINCINNATI – August 15, 2024 – AtriCure, a global leader in surgical treatments for atrial fibrillation, post-operative pain management, and left atrial appendage management, announced plans today to further invest in the expansion of its global corporate headquarters campus on Innovation Way in Mason, Ohio. This multi-year phased investment will fuel AtriCure’s research, development and manufacturing capabilities, building upon the critical mass of the City of Mason’s MedTech and life sciences clusters.

AtriCure’s expanded campus will house up to 120,000 square feet of new laboratory, R&D, office and advanced manufacturing space. The new construction includes expansion of the company’s existing Mason Manufacturing Building with the construction of adjoining space.

“With our history of delivering innovative solutions and advancing standards of care that improve lives around the globe, we are thrilled to continue our expansion in Mason, Ohio,” said Michael Carrel, AtriCure’s President and CEO. “This project underscores continued growth as we pursue our commitment to reaching more patients, reinforces our connection to the community, and reflects our strong and cooperative partnership with the city of Mason and the state of Ohio.”

To learn more, please see the news release here.